Orexigen â„¢ Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of central nervous system disorders including obesity, today announced that the Company will be presenting data on its two product candidates for the treatment of obesity, Contrave TM and Empatic TM , in five sessions at The Obesity Society ' s Annual Scientific Meeting (NAASO) in New Orleans, ...
More...
More...